NLS Pharmaceutics and Kadimastem complete pre-IND diabetes meeting with FDA
PremiumThe FlyNLS Pharmaceutics and Kadimastem complete pre-IND diabetes meeting with FDA
1M ago
NLS Pharmaceutics and Partners Achieve Milestone in Diabetes Treatment Development
Premium
Company Announcements
NLS Pharmaceutics and Partners Achieve Milestone in Diabetes Treatment Development
1M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
NLS Pharmaceutics files to sell 645,161 common shares for holders
PremiumThe FlyNLS Pharmaceutics files to sell 645,161 common shares for holders
2M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
NLS Pharmaceutics Amends Merger Agreement with Kadimastem
Premium
Company Announcements
NLS Pharmaceutics Amends Merger Agreement with Kadimastem
2M ago
NLS Pharmaceutics Submits Research Abstracts to ASCP 2025
PremiumCompany AnnouncementsNLS Pharmaceutics Submits Research Abstracts to ASCP 2025
2M ago
NLS Pharmaceutics Launches Preclinical Program for Fentanyl Dependence Treatment
Premium
Company Announcements
NLS Pharmaceutics Launches Preclinical Program for Fentanyl Dependence Treatment
2M ago
NLS Pharmaceutics and Kadimastem Move Toward Merger Approval
Premium
Company Announcements
NLS Pharmaceutics and Kadimastem Move Toward Merger Approval
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100